Technical Analysis for SRPT - Sarepta Therapeutics, Inc.

Grade Last Price % Change Price Change
F 74.5 -0.15% -0.11
SRPT closed up 2.53 percent on Thursday, May 6, 2021, on 1.93 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical SRPT trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup -0.15%
Upper Bollinger Band Walk Strength -0.15%
Outside Day Range Expansion -0.15%
Upper Bollinger Band Touch Strength -0.15%
Calm After Storm Range Contraction 2.38%
Earnings Movers Other 2.38%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.65%
Earnings Movers Other 0.65%
Inside Day Range Contraction 0.65%
Upper Bollinger Band Touch Strength 0.65%
Older End-of-Day Signals for SRPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 2 hours ago
Up 3% about 6 hours ago
Upper Bollinger Band Resistance about 6 hours ago
Rose Above Upper Bollinger Band about 6 hours ago
Up 2% about 6 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Sarepta Therapeutics, Inc. Description

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen, an antisense PMO-based therapeutic, which is in Phase IIb clinical development for the treatment of individuals with Duchenne muscular dystrophy. The company is also involved in developing treatments that are in Phase I clinical trials for infectious diseases, including AVI-7288 for Marburg virus; and AVI-7100 for H1N1 influenza virus. In addition, it focuses on developing preclinical research product candidates for the treatment of other neuromuscular, infectious, and rare diseases. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Clinical Development Infectious Diseases Rare Diseases Clinical Research Influenza Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Therapeutic Gene Modulation Antisense RNA Sarepta Therapeutics

Is SRPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 181.83
52 Week Low 68.04
Average Volume 1,077,294
200-Day Moving Average 121.53
50-Day Moving Average 77.29
20-Day Moving Average 71.92
10-Day Moving Average 72.56
Average True Range 3.19
ADX 25.41
+DI 27.90
-DI 17.02
Chandelier Exit (Long, 3 ATRs ) 68.96
Chandelier Exit (Short, 3 ATRs ) 77.60
Upper Bollinger Band 75.59
Lower Bollinger Band 68.26
Percent B (%b) 0.87
BandWidth 10.20
MACD Line -0.95
MACD Signal Line -1.80
MACD Histogram 0.8564
Fundamentals Value
Market Cap 5.89 Billion
Num Shares 78.9 Million
EPS -8.14
Price-to-Earnings (P/E) Ratio -9.17
Price-to-Sales 23.81
Price-to-Book 13.56
PEG Ratio 159.25
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 81.21
Resistance 3 (R3) 81.25 79.10 80.11
Resistance 2 (R2) 79.10 77.42 79.08 79.74
Resistance 1 (R1) 76.85 76.38 77.98 76.81 79.38
Pivot Point 74.70 74.70 75.26 74.68 74.70
Support 1 (S1) 72.45 73.02 73.58 72.41 69.84
Support 2 (S2) 70.30 71.98 70.28 69.48
Support 3 (S3) 68.05 70.30 69.11
Support 4 (S4) 68.01